Vapotherm, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 08, 2023 at 04:17 pm EDT
Share
Vapotherm, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 16.04 million compared to USD 12.97 million a year ago. Net loss was USD 14.79 million compared to USD 42.68 million a year ago. Basic loss per share from continuing operations was USD 2.32 compared to USD 12.88 a year ago. Diluted loss per share from continuing operations was USD 2.32 compared to USD 12.88 a year ago.
For the six months, sales was USD 33.77 million compared to USD 34.59 million a year ago. Net loss was USD 32.88 million compared to USD 65.62 million a year ago. Basic loss per share from continuing operations was USD 5.76 compared to USD 19.84 a year ago. Diluted loss per share from continuing operations was USD 5.76 compared to USD 19.84 a year ago.
Vapotherm, Inc. is a developer and manufacturer of advanced respiratory technology. It develops non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. It is focused on the care of patients suffering from respiratory distress, whether associated with lung diseases, such as chronic obstructive pulmonary disease, congestive heart failure, pneumonia, asthma, and COVID-19 or other systemic conditions. Its device solutions are focused on High Velocity Nasal Insufflation, which delivers non-invasive ventilatory support to patients by providing heated, humidified, oxygenated air at high velocities through a small-bore nasal interface, and on closed loop control systems, such as its Oxygen Assist Module, designed to automatically maintain a patients pulse oxygen saturation levels within a specified range for a defined period of time. Its digital solutions are focused on remote patient monitoring, using algorithms to predict respiratory episodes.
VAPOTHERM, INC. 
